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Objective: The aim of this study was to investigate whether the WSQ is an adequate test to screen for the 
presence of depressive and anxiety disorders in clinical practice. 
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Conclusions: In this study group, the WSQ was a relatively good screening tool to identify individuals 
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disorders (except for post-traumatic stress disorders and specific phobias). However, in case of a positive 
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Background: There is a need for brief screening methods for psychiatric disorders in clinical practice. This study assesses the
validity and accuracy of a brief self-report screening questionnaire, the Web Screening Questionnaire (WSQ), in detecting
psychiatric disorders in a study group comprising the general population and psychiatric outpatients aged 18 years and older.
Objective: The aim of this study was to investigate whether the WSQ is an adequate test to screen for the presence of depressive
and anxiety disorders in clinical practice.
Methods: Participants were 1292 adults (1117 subjects from the general population and 175 psychiatric outpatients), aged 18
to 65 years. The discriminant characteristics of the WSQ were examined in relation to the (“gold standard”) Mini-International
Neuropsychiatric Interview-Plus (MINI-Plus) disorders, by means of sensitivity, specificity, area under the curve (AUC), and
positive and negative predictive values (PPVs, NPVs).
Results: The specificity of the WSQ to individually detect depressive disorders, anxiety disorders, and alcohol abuse or
dependence ranged from 0.89 to 0.97 for most disorders, with the exception of post-traumatic stress disorder (0.52) and specific
phobia (0.73). The sensitivity values ranged from 0.67 to 1.00, with the exception of depressive disorder (0.56) and alcohol abuse
or dependence (0.56). Given the low prevalence of separate disorders in the general population sample, NPVs were extremely
high across disorders (≥0.97), whereas PPVs were of poor strength (range 0.02-0.33).
Conclusions: In this study group, the WSQ was a relatively good screening tool to identify individuals without a depressive or
anxiety disorder, as it accurately identified those unlikely to suffer from these disorders (except for post-traumatic stress disorders
and specific phobias). However, in case of a positive WSQ screening result, further diagnostic procedures are required.
(JMIR Ment Health 2017;4(3):e35)   doi:10.2196/mental.5453
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Introduction
Structured diagnostic interviews such as the Composite
International Diagnostic Interview (CIDI) [1] and the Structured
Clinical Interview for DSM-III-R (SCID) [2] are considered
gold standards in research, used to diagnose psychiatric disorders
in a standardized way [1,3,4]. However, they are less suitable
for clinical practice because their administration is time
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consuming, and they can only be administered by well-trained
interviewers [5]. The Mini-International Neuropsychiatric
Interview-Plus (MINI-Plus) [6] is a much shorter diagnostic
interview with diagnostic properties similar to the CIDI [6,7].
However, the MINI-Plus also requires trained interviewers and
takes up to 30 min to complete, making it costly for routine use
in clinical practice. Therefore, because these interviews are
often impractical to be used as a screener for routine use, a
reliable, valid, and briefly self-rating screening questionnaire
is desired. The Web Screening Questionnaire (WSQ) [8] was
developed to quickly screen for common psychiatric disorders
(ie, anxiety or depressive disorders and alcohol abuse or
dependence). This Internet-based, self-report screening
questionnaire consists of only 15 items and requires less than
5 min to complete. The WSQ has good to excellent validity for
social phobia, panic disorder with agoraphobia, agoraphobia
(without panic disorder), obsessive compulsive disorder (OCD),
and alcohol abuse or dependence (sensitivity ranges from
0.72-1.00; and specificity from 0.63-0.80) [8]. Slightly more
modest psychometric properties were reported for depressive
disorder, generalized anxiety disorder (GAD), post-traumatic
stress disorder (PTSD), specific phobia, and panic disorder
(without agoraphobia), that is, sensitivity 0.80 to 0.93; specificity
0.44 to 0.51 [8]. These data reflect the validation of the WSQ
compared with CIDI diagnoses ascertained in the general
population with 6-month prevalence rates of the Diagnostic and
Statistical Manual, 4th edition-Text Revision (DSM-IV-TR)
diagnoses [9]. As the WSQ screens for current symptoms [8],
it is relevant to test the WSQ against current DSM-IV diagnoses.
This study examines the validity and accuracy of the WSQ as
a screener against 1-month prevalence MINI-Plus disorders
covered by the WSQ. The study group mainly comprised a
general population sample recruited from primary care
registrations. To increase the prevalence of psychiatric disorders,
we enriched this general population sample with a smaller
sample of psychiatric outpatients to form one large study group.
Methods
Sample
For this study, to ensure statistical power of the analyses,
participants from a general population study and participants
from a pragmatic randomized controlled trial (RCT) conducted
in clinical practice were combined into one large study group.
The 1302 participants from the general population were recruited
(from November 2009 to January 2011) from the administration
of eight university-affiliated general practices in the vicinity of
Leiden, the Netherlands. In the Netherlands, since nearly 100%
of the population is registered with a general practitioner (GP),
the primary care sample is equivalent to a general population
sample [10,11]. To form a nonpatient control group,
representative of a population referred for suspected (but not
necessarily diagnosed with) mood, anxiety and/or somatoform
disorders, four exclusion criteria were applied by Schulte-van
Maaren and colleagues (2013) [12]: (1) treatment in a secondary
psychiatric care center in the last 6 months for psychiatric
problems and/or dependence on alcohol or drugs; (2) hearing
impairment or limited cognitive abilities such as aphasia, severe
dyslexia, or dementia; (3) illiteracy or insufficient mastery of
the Dutch language; and (4) suffering from a potentially lethal
disorder. The initial study was designed to generate reference
values in primary care for questionnaires used in the assessment
of psychopathology. Details of this study by Schulte-van Maaren
and colleagues (2013) are described elsewhere [12]. This study
focuses on the main aspects relevant for the current research
question.
The general population sample derived from the study of
Schulte-van Maaren et al (2013) [12] was enriched with a sample
of 182 secondary care outpatients who were originally recruited
for a pragmatic RCT and in whom the WSQ and the MINI-Plus
were assessed at baseline. This RCT is published in Meuldijk
and colleagues (2012) [13]. The trial was conducted (from
March 2010 to December 2012) at five outpatient mental health
clinics in and around Leiden of Rivierduinen (RD), a secondary
Regional Mental Health Provider (RHMP) in the province of
South-Holland, the Netherlands. Eligible participants were
patients aged 18-65 years, referred to the mental health clinics
by their GP for the treatment of a current mild to moderate
anxiety and/or depressive disorder including depressive disorder,
dysthymia, panic disorder (with or without agoraphobia), social
phobia, specific phobia, GAD, OCD, and PTSD. Exclusion
criteria were (1) suicidal or homicidal risk; (2) delusions,
hallucinations, bipolar, or psychotic disorder; (3) severe social
dysfunction; and/or (4) insufficient knowledge of the Dutch
language.
In both subsamples, the assessment included (among others)
the MINI-Plus and the WSQ. Of the initial general population
sample of 1302 participants, 185 had incomplete WSQ data,
leaving 1117 participants for inclusion in the present analysis.
Of the outpatient sample of 182 patients, 6 had incomplete WSQ
data and 1 MINI-Plus interview was incomplete, resulting in
175 outpatients. Thus, the (combined) study group for this study
consisted of (1117+175) 1292 participants.
The study protocol for both samples was approved by the
medical ethical committee of the Leiden University Medical
Center.
Web Screening Questionnaire (WSQ)
The WSQ (see Multimedia Appendix 1) is a 15-item, self-report
instrument that screens for depressive disorder, GAD, panic
disorder with or without agoraphobia, social phobia, specific
phobia, OCD, PTSD, agoraphobia, suicidality, and alcohol abuse
or dependence [8]. The RCT of Meuldijk and colleagues
excluded participants with a moderate to high suicidality risk
and/or suicidal ideation [13]. Therefore, in this study, the WSQ
item that assesses the risk of suicide or self-harm was not
included in the analysis. The WSQ is based on the screening
questionnaire of Marks and colleagues [14]. Compared with the
6-months CIDI diagnoses, in the general population, the WSQ
has moderate to good screening properties (sensitivity 0.72 to
1.00; specificity 0.44 to 0.80) [8]. Depression, panic disorder
with agoraphobia, and alcohol dependence were each assessed
by two items, whereas the other disorders were assessed by
single items. The same WSQ cut-off scores were applied as
used in the study by Donker and colleagues (2006) [8].
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The MINI-Plus 5.0.0, Dutch version, was used as the “gold
standard” reference [6]. The MINI-Plus is a structured and
standardized diagnostic interview used to determine the most
common psychiatric disorders according to axis I DSM-IV-TR
[9] and the International Classification of Diseases and Related
Health Problems (ICD-10) [6].
For this study, we used the diagnoses of (1) mood disorders
(depression and dysthymia), (2) anxiety disorders (panic disorder
with or without agoraphobia, agoraphobia, social phobia,
specific phobia, GAD, PTSD [type I or single trauma], and
OCD), and (3) alcohol abuse or dependence. The MINI-Plus
has good psychometric properties and is widely used to support
diagnostics in psychiatry. The MINI-Plus was conducted by
trained research nurses. As the WSQ screens for current
diagnoses, only the 1-month MINI-Plus was used.
Statistical Analyses
The discriminant function of the WSQ was assessed for each
of the MINI-Plus Axis 1 DSM-IV-TR disorders for which it
screens, using sensitivity, specificity, receiver operating
characteristics (ROC) curve (area under the curve [AUC]) [15],
and positive and negative predictive values (PPVs, NPVs).
Specificity was calculated as the proportion of patients who did
not have the MINI-plus diagnosis and who had a negative WSQ
screen. Sensitivity was determined as the proportion of patients
with a MINI-Plus psychiatric diagnosis who had a positive WSQ
screen for the same disorder. The AUC, (interpreted as the
probability that a randomly selected clinical case will score
higher on the test than a noncase), is not sensitive to prevalence
and is proposed to correct this problem [16]; it can range from
0.50 (worthless test) to 1.00 (perfect test). Following Agresti
(2002) [17], we considered the AUC to be of excellent evidence
of concordance if ≥0.90, good evidence of concordance if
between 0.80 and 0.90, acceptable although only average if
between 0.70 and 0.80, and poor if <0.70. The PPV was
calculated as the percentage of participants with a positive test
on the WSQ who actually had the disorder according to the
MINI-Plus diagnosis, whereas the NPV was calculated as the
percentage of participants with a negative test that did not have
the disorder according to the MINI-Plus. As the PPV and the
NPV strongly depend on the prevalence of the disorder, we
calculated these indices on the general population sample only,
without the enrichment; otherwise, the results would be
artificially inflated. Furthermore, WSQ cut-off scores were
applied as originally recommended by Donker et al 2006 [8]
and slightly adapted to fit within routine outcome monitoring
(ROM), a monitoring system for psychiatric patient care [18].
All analyses were conducted using IBM SPSS version 20.0 for
Windows.
Results
Demographics and Prevalence of Diagnostic and
Statistical Manual, 4th Edition-Text Revision
(DSM-IV-TR) Diagnoses
Characteristics of the two subsamples are presented in Table 1.
In the total study group, the mean age was 39.6 years (range
18-65, standard deviation [SD]=12.6), and 60.53% (782/1292)
of the participants were female. Most participants were of Dutch
origin (1223/1292; 94.66%) and had completed a higher level
of education (972/1292; 75.23%). At baseline, 77.32% of the
participants (999/1292) were employed, and 66.18% (855/1292)
were married. In the total group, 79 participants (6.11%) met
the DSM-IV-TR MINI-Plus criteria for a current (ie, within the
past month) depressive (with or without anxiety) disorder. Of
the total group, 139 participants (10.76%) met the criteria for
an anxiety with or without a depressive disorder; these
participants were diagnosed according to the common subtypes
of anxiety as indicated in Table 2. In addition, 55 participants
(4.26%) met the criteria for current alcohol abuse or dependence
disorder. The majority of the study group (934/1292, 72.29%)
did not pass the threshold for a current MINI-Plus diagnosis. It
is recognized that the two study groups are not the same. The
study population contains selected subgroups of particular
interest; the difference in clinical and demographic
characteristics within these subgroups contributes to define the
target population.
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Table 1. Baseline sociodemographic and clinical characteristics of the two subsamples and the total study group (n=1292). The MINI International









39.6 (12.56)36.67 (12.40)40.04 (12.53)Age (years), mean (SDb)
Gender, n (%)
782 (60.53)70 (40.0)712 (63.74)Female
Ethnical backgroundc , n (%)
1223 (94.66)160 (91.4)1116 (99.91)Dutch
63 (4.88)10 (5.7)53 (4.74)Other
Educational statusd , n (%)
314 (24.30)64 (36.6)250 (22.38)Lower education
972 (75.23)106 (60.6)866 (77.53)Higher education
Employment status, n (%)
999 (77.32)85 (48.6)914 (81.83)Employed
287 (22.21)85 (48.6)202 (18.08)Unemployed or retired
Marital status, n (%)
855 (66.18)89 (50.9)766 (68.58)Married or cohabitating
Clinical characteristics or MINIe -Plus Diagnosisf , n (%)
79 (6.11)67 (38.3)12 (1.07)Depressive (with or without anxiety) disorder
139 (10.76)79 (45.1)60 (5.37)Anxiety (with or without depressive) disorder
28 (2.17)24 (13.7)4 (0.36)Panic disorder (without agoraphobia)
64 (4.95)37 (21.1)27 (2.42)Agoraphobia
20 (1.5518 (10.3)2 (0.18)Panic disorder with agoraphobia
19 (1.47)9 (5.1)10 (0.09)Social phobia
12 (0.93)3 (1.7)9 (0.81)Specific phobia
35 (2.71)22 (12.6)13 (1.16)Generalized anxiety disorder
19 (1.47)14 (8.0)5 (0.45)Posttraumatic stress disorder
9 (0.70)3 (1.7)6 (0.54)Obsessive compulsive disorder
55 (4.26)4 (2.3)51 (4.57)Alcohol abuse or dependence
934 (72.29)32 (18.3)902 (80.75)No current DSM-IV-TRg diagnosish
aDemographic data; ethnic background, educational status, and employment status are missing for 6 participants (1 participant from the general population
sample, and 5 outpatients).
bSD: standard deviation.
cDutch ethnic background was assumed when the participant was born in the Netherlands.
dLower education=having completed elementary school, lower general primary education, or no education at all; higher education=more than lower
education (includes university).
eMINI: Mini-International Neuropsychiatric Interview.
fClinical characteristics or diagnosis were missing for 1 participant.
gDSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th edition-Text Revision.
hDenotes participants who did not pass the threshold for having a current Axis- I DSM-IV-TR diagnosis according to the MINI-Plus interview.
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Table 2. Agreement between the Mini-International Neuropsychiatric Interview (MINI)-Plus and the Web Screening Questionnaire (WSQ) for individual
disorders in the total sample (n=1292). Numbers in the table reflect the use of each screening subscale to detect any diagnosis rather than only the
diagnosis associated with the subscale. WSQ cut-off scores were derived from the original cut-offs recommended by Donker et al (2009) [8]. WSQ
cut-off scores: depression: Q1≥5 and Q2=1; panic disorder: Q4≥1; agoraphobia Q5=1; panic disorder with agoraphobia Q4≥1 and Q5=1; social phobia:
Q8=1 and Q9=1; specific phobia: Q6 or Q7=1; generalized anxiety disorder (GAD): Q3≥2; post-traumatic stress disorder (PTSD): Q10=1 or Q11=1;
































































































1147249031121 (9.37)55 (4.26)Alcohol abuse or de-
pendence
aDSM- IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th edition-Text Revision.
bMINI: Mini International Neuropsychiatric Interview; MINI-Plus 5.0.0.
cWSQ: Web Screening Questionnaire.
dAUC: area under the curve.
Concordance Between Mini-International
Neuropsychiatry Interview (MINI)-Plus and Web
Screening Questionnaire (WSQ)
The concordance between each diagnosis classified according
to the DSM-IV-TR with the MINI-Plus and the WSQ
questionnaire is presented in Table 2. Specificity was high (range
0.89-0.97) for most individual disorders, with the exception of
specific phobia (0.73) and PTSD (0.52). Sensitivity was
substantial to high (0.67 to 1.00) for the majority of disorders.
The exceptions were depressive disorder (0.58) and alcohol
abuse or dependence (0.56). All AUC values were good to
excellent (≥0.82) for the individual disorders. The best
discriminating subscale was panic disorder with agoraphobia
(AUC=0.99), followed by panic disorder (AUC=0.98) and social
phobia (AUC=0.95). Figure 1 presents the discriminative power
of each subscale of the WSQ. Data on PPCs and NPVs are given
in Table 3. These indices were calculated for the general
population subsample only because of the strong relation to the
prevalence of the disorders. Despite generally strong
discriminative power, the PPV was of poor strength ranging
from 0.01 (PTSD) to 0.33 (agoraphobia); the NPVs were
uniformly high (≥0.97) for all scales.
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Figure 1. Distribution of the MINI-Plus diagnosis for the corresponding Web Screening Questionaire (WSQ) subscales in the study sample (N = 1292)
MINI-Plus=The MINI International Neuropsychiatric Interview-Plus 5.0.0. WSQ=Web Screening Questionnaire. WSQ cut-off scores were derived
from the original cut-offs recommended by Donker and colleagues (2009) [8]. WSQ cut-off scores: depression: Q1≥5 and Q2=1; panic disorder: Q4
≥1; agoraphobia: Q5=1; panic disorder with agoraphobia Q4≥1 and Q5=1; social phobia: Q8=1 and Q9=1; specific phobia: Q6 or Q7=1; generalized
anxiety disorder (GAD): Q3≥2; post-traumatic stress disorder (PTSD): Q10=1 or Q11=1; obsessive compulsive disorder (OCD): Q12≥1; and alcohol
abuse or dependence : Q13≥2 & Q14≥3. MINI-Plus: The Mini-International Neuropsychiatric Interview-Plus 5.0.0. WSQ: Web Screening Questionnaire.
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Table 3. Predictive value of the Web Screening Questionnaire (WSQ) for individual disorders according to the Mini-International Neuropsychiatry
Interview (MINI)-Plus in the general population subsample (n=1117). Numbers in the table reflect the use of each screening subscale to detect any
diagnosis rather than only the diagnosis associated with the subscale. WSQ cut-off scores were derived from the original cut-offs recommended by
Donker et al (2009) [8]. WSQ cut-off scores: depression: Q1≥5 and Q2=1; panic disorder: Q4≥1; agoraphobia: Q5=1; panic disorder with agoraphobia
Q4≥1 and Q5=1; social phobia: Q8=1 and Q9=1; specific phobia: Q6 or Q7=1; generalized anxiety disorder (GAD): Q3≥2; post-traumatic stress disorder






































































984238228110 (9.85)51 (4.57)Alcohol abuse or dependence
aDSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th edition-Text Revision.
bMINI: Mini International Neuropsychiatric Interview; MINI-Plus 5.0.0.
cWSQ: Web Screening Questionnaire.
dPPV: positive predictive value.
eNPV: negative predictive value.
Discussion
Principal Findings
This study evaluated the feasibility of the WSQ to screen for
DSM-IV-TR diagnoses of depressive disorder, anxiety disorders,
and alcohol abuse or dependence. Overall, the WSQ was
relatively successful in discriminating between individuals with
and without a MINI-Plus diagnosis. However, if the WSQ tests
positive for a psychiatric disorder, further examination is
warranted because of the poor PPVs. Thus, most patients who
tested positively, did not receive a MINI-Plus diagnosis.
The adequate strength of the findings regarding sensitivity,
specificity, and AUC values suggest that the WSQ has some
desirable screening characteristics. Its high sensitivity suggests
that it may help to confirm the absence of most of these
psychiatric diagnoses, that is, ruling out the disorders. However,
the exceptions are depressive disorder, specific phobia, PTSD,
and alcohol abuse or dependence, for which the agreement in
ruling out these psychiatric disorders was lower. In the general
population subsample, the NPVs were high, but the PPVs were
relatively low compared with the MINI-Plus results. Although
the PPVs and NPVs are not intrinsic to the test, they are directly
related to the prevalence of the disease in the population.
Assuming all other factors remain constant, PPV increases with
increasing prevalence, and NPV decreases with an increase in
prevalence.
Together with the results reported by Donker and colleagues
[8] who found AUCs of 0.65 to 0.83 in their validation of the
WSQ against DSM-IV-TR diagnoses with the CIDI in the
general population, the present results indicate that the WSQ
has potential as a screener, ruling out the presence of a disorder.
Our findings are in line with other validation studies comparing
brief screening tools with longer ones and also showing the
feasibility of these short screening instruments. This applies,
for example, to the Psychiatric Diagnostic Screening
Questionnaire (PDSQ) in outpatients [19,20] and the Mental
Health Inventory 5 (MHI-5) and the Anxiety and Depression
Detector (ADD) for primary care populations [21-23].
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A strength of this study is the large number of participants
included. Another strength is that our MINI-Plus data allowed
to determine the concordance of the WSQ with the last 1-month
DSM-IV-TR diagnoses, providing an accurate measure of the
current (or very recent) prevalence of this mental disorder. In
contrast, Donker and colleagues (2009) [8] used 6-month
prevalence rates, which implies that some disorders could have
receded during the past 5 months.
A limitation of this study is that all the GP practices included
were affiliated with a university hospital. Because such practices
tend to have more focus on research and training than
nonaffiliated practices, this may have introduced bias in the
study group population. Moreover, the study group was mainly
compiled from participants included in an earlier general
population study [12]; these participants did not have psychiatric
treatment for 6 months before recruitment and did not report
dependence on alcohol or other drugs. Although we made
considerable effort to compensate for this potential source of
bias in recruitment by adding a psychiatric outpatient subsample
[13], the prevalence of psychiatric disorders in our general
population subsample was substantially lower than expected
from population-based surveys in the Netherlands [24,25].
Therefore, it is likely that we probably included an overly
healthy study group, thereby limiting the generalizability of
these results to the general population or other patient samples.
Therefore, the present results need to be confirmed in other
study populations. As a result, the NPV estimates may have
been too high and the PPV too low. Our findings with regard
to the predictive value must be considered extreme, given the
very low prevalence of disorders in the present sample. In
addition, as the number of participants with certain conditions
was small, this yielded less precise effect estimates, which
should be taken into account when interpreting these results.
Predictive values from one study should not be transferred to
another setting with a different prevalence of the disease in the
population. However, our estimates of the sensitivity, specificity,
and AUC are not affected by this limitation. Moreover,
reconsidering the diagnostic criteria and the screening items
used for the individual WSQ items could contribute to a higher
accuracy of detecting disorders and higher positive and
predictive values.
A final limitation is that our sample was restricted to
Dutch-speaking individuals able to write (illiterate or non-Dutch
speaking persons were excluded); this may also limit the
generalizability of our results, especially across different
immigrant groups. In addition, future research could investigate
the impact of demographic factors on our study results. Although
it is generally assumed that structured diagnostic interviews (ie,
the MINI-Plus and SCID) are the “gold standards” for the
assessment of diagnoses in psychiatric research, these standards
have their limitations. One advantage for reproducibility is that
it is fully clear what standardized procedures had been followed.
However, the notion that mental disorders (eg, depression and
anxiety) are entities that can be diagnosed remains debatable,
despite the apparent clinical value of such diagnoses.
Conclusions
The WSQ is a short questionnaire to screen for depression,
GAD, panic disorder with or without agoraphobia, social phobia,
specific phobia, OCD, PTSD, and alcohol abuse or dependence.
In has proven useful in the general population to screen for the
6-months prevalence for these disorders, compared with the
CIDI as gold standard [8]. This study yielded similar results,
with the 1-month prevalence of these disorders in the MINI-Plus
in a general practice population, combined with psychiatric
outpatients. Taken together, exploring the agreement between
both instruments, or findings, indicates that the WSQ can
(potentially) be used as a brief and less costly screening tool
for depressive or anxiety disorders (except for PTSD and
specific phobia). The WSQ seems a promising tool with a
two-step diagnostic approach, for example, in primary care. It
could assist health care providers in screening patients before
consultation. Patients who screen positive should undergo more
extensive diagnostic procedures, whereas a negative screen
indicates that it is highly unlikely that further evaluation would
be useful. With such an approach, diagnostic accuracy might
be increased and costly diagnostic procedures limited or avoided.
However, this study had several limitations which should be
considered when interpreting and generalizing our finding to
other groups. For example, participant recruitment was not
standard, and recruitment barriers could not be completely
eliminated. Also, in our study group, the prevalence of
psychiatric disorders was lower than expected. Moreover,
concern still exists about the usefulness of the WSQ in its current
form; some revision of the scale may be required to improve
its psychometric properties. Future research exploring the
feasibility of the WSQ for assessing mental health in general
practice might be a further step in the economization and
optimization of mental health care.
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